Editorial Recommendations of the Month

Key articles from high impact journals in last month

January 2022

Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis

Nielsen OH, Gubatan JM, Juhl CB, Streett SE, Maxwell C.

Published Jan 2022, in the Clinical gastroenterology and hepatology

Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With Prior Malignancy: A Retrospective Cohort Study

Vedamurthy A, Gangasani N, Ananthakrishnan AN.

Published Jan 2022, in the Clinical gastroenterology and hepatology

Natural history of inflammatory bowel disease: a comparison between the East and the West

Song EM, Yang SK.

Published Dec 2021, in the Intestinal research.

Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease

D'Haens G, Rieder F, Feagan BG, Higgins PDR, Panés J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; International Organization for Inflammatory Bowel Disease Fibrosis Working Group.

Published Jan 2022, in the Gastroenterology

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

Flanagan E, Prentice R, Wright EK, Gibson PR, Ross AL, Begun J, Sparrow MP, Goldberg R, Rosella O, Burns M, Kiburg KV, Bell SJ.

Published Dec 2021, in the Alimentary pharmacology & therapeutics.

COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation

Lev-Tzion R, Focht G, Lujan R, Mendelovici A, Friss C, Greenfeld S, Kariv R, Ben-Tov A, Matz E, Nevo D, Barak-Corren Y, Dotan I, Turner D.

Published Dec 2021, in the Clinical gastroenterology and hepatology

Adherence to mediterranean diet in patients with inflammatory bowel disease

Fiorindi C, Dinu M, Gavazzi E, Scaringi S, Ficari F, Nannoni A, Sofi F, Giudici F.

Published Dec 2021, in the Clinical nutrition ESPEN

Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel

Avni-Biron I, Bar-Gil Shitrit A, Koslowsky B, Levartovsky A, Kopylov U, Weisshof R, Aviv Cohen N, Maharshak N, Hovel D, Israeli E, Naftali T, Goren I, Snir Y, Ollech JE, Banai-Eran H, Broitman Y, Sharar-Fischler T, Dotan I, Yanai H.

Published Dec 2021, in the Digestive and liver disease

Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues

Peyrin-Biroulet L, Sandborn WJ, Panaccione R, Domènech E, Pouillon L, Siegmund B, Danese S, Ghosh S.

Published Dec 2021, in the Digestive and liver disease

Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Tariq R, Syed T, Yadav D, Prokop LJ, Singh S, Loftus EV Jr, Pardi DS, Khanna S.

Published Dec 2021, in the Journal of clinical gastroenterology

Archive